doxorubicin liposomal (cont.)
IN THIS ARTICLE
Who should not use doxorubicin liposomal (Doxil)?
Do not use doxorubicin liposomal without first talking to your doctor if you have
The use of doxorubicin liposomal may be dangerous if you have any of the conditions listed above.
Doxorubicin liposomal is in the FDA pregnancy category D. This means that doxorubicin liposomal is known to be harmful to an unborn baby. Do not use doxorubicin liposomal without first talking to your doctor if you are pregnant. Discuss with your doctor the appropriate use of birth control during, and for several months following, treatment with doxorubicin liposomal if necessary.
Because of the potential for serious side effects in a nursing infant, breast-feeding should be avoided during treatment with doxorubicin liposomal.
How should I use doxorubicin liposomal (Doxil)?
Doxorubicin liposomal should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.
Your doctor will determine the correct amount and frequency of treatment with doxorubicin liposomal depending upon the type of cancer being treated and other factors. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.
Your doctor will probably want you to have regularly scheduled blood tests and other medical evaluations during treatment with doxorubicin liposomal to monitor progress and side effects.
Skin accidentally exposed to doxorubicin liposomal should be rinsed thoroughly with soap and warm water.
Your healthcare provider will store doxorubicin liposomal as directed by the manufacturer. If you are storing doxorubicin liposomal at home, follow the directions provided by your healthcare provider.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Get the latest treatment options.